By David Gorski
It figures that I couldn’t go three weeks into 2014 without the topic of Stanislaw Burzynski rearing its ugly head. I had hoped to make it to February or even beyond before feeling the gravitational tug of the wretched hive of ignominious and unethical behavior, but here we are, only 20 days into the new year. So be it.
The year 2013 finished with serious setbacks for Stanislaw Burzynski and his unproven cancer treatment that he dubbed “antineoplastons” (ANPs) way back in the early 1970s. As you might recall, in November, two things happened. First, the FDA released its initial reports on its inspection of the Burzynski Clinic and Burzynski Research Institute (BRI) carried out from January to March 2013. Liz Szabo published a fantastic expose of Stanislaw Burzynski. They were damning in the extreme, pointing out the shoddy operating methods of the institutional review board (IRB) used by the BRI to approve and oversee Burzynski’s “clinical trials” (and I use the term loosely) of ANPs. Violations included using expedited approvals to review single patient protocols, something so far outside the purview of what the expedited approval process was intended for, namely approving minor tweaks to human subjects research …read more
Read more here: http://www.sciencebasedmedicine.org/stanislaw-burzynski-trying-to-relive-his-success-beating-the-rap-in-the-1990s/?utm_source=rss&utm_medium=rss&utm_campaign=stanislaw-burzynski-trying-to-relive-his-success-beating-the-rap-in-the-1990s